Relay Therapeutics, focused on solid tumors, seeks to raise $250M in IPO - STAT

Relay Therapeutics, focused on solid tumors, seeks to raise $250M in IPO - STAT

More reads

• Relay Therapeutics, focused on solid tumors, seeks to raise $250 million in an IPO. (Boston Globe)
• Boehringer Ingelheim-backed COVID researchers identify new antibodies to fight the virus. (FierceBiotech)